Featured

Researchers of Nobel class: Citation Laureates 2023

David Pendlebury

Head of Research Analysis at the Institute for Scientific Information

arrow_forward Read more
Intellectual Property
IP cost forecasting: adding accuracy, removing guesswork [New Report]
arrow_forward Read more
Clarivate Insights
How Clarivate uses Artificial Intelligence you can trust to transform your world
arrow_forward Read more
Life Sciences and Healthcare
September 26, 2023

Real world data’s role in strategic site selection
Life Sciences and Healthcare
August 8, 2023

Four key points on the Inflation Reduction Act
Matthew Arnold
Principal Analyst
Clarivate
Life Sciences and Healthcare
August 7, 2023

Dialog Solutions becomes Clarivate
Vikram Mishra
Senior Product Marketing Manager
Clarivate
Life Sciences and Healthcare
August 1, 2023

Clarivate Integrates Dialog Solutions Products and Services into Life Sciences & Healthcare Portfolio
Henry Levy
President, Life Sciences and Healthcare
Clarivate
Intellectual Property
July 24, 2023

Pharmas and medtechs flex brand protection among Top 100 New Brands for 2023
Matthew Arnold
Principal Analyst
Clarivate
Life Sciences and Healthcare
July 6, 2023

The future of scRNA-Seq applicability
Octavio Morante-Palacios
Bioinformatics Consultant, DTS
Clarivate
Life Sciences and Healthcare
July 5, 2023

The AMJEVITA impact: Innovative U.S. biosimilar pricing models
Yashu Malhotra
Healthcare Research and Data Analyst, Biosimilars
Clarivate
Life Sciences and Healthcare
June 29, 2023

Generative AI’s potential to speed delivery of improved patient outcomes
Henry Levy
President, Life Sciences and Healthcare
Clarivate
Life Sciences and Healthcare
June 26, 2023

Regulators and HTAs tune in to patient preference data
Sarah Knight
Director, Clinical Outcomes Assessment
Clarivate
Life Sciences and Healthcare
June 22, 2023

Mind the gap: Using advanced analytics to find and fill the holes in real world data
Life Sciences and Healthcare
June 21, 2023

‘Regulatory lasagne’ and the impact of the European AI Act on medtech
Life Sciences and Healthcare
May 31, 2023

Pharma-biotech partnerships take on new urgency as patent cliffs loom
Life Sciences and Healthcare
May 24, 2023

Gene therapies transform rare disease treatment: hope for patients amidst regulatory, payer and developer challenges
Matthew Arnold
Principal Analyst
Clarivate
Life Sciences and Healthcare
May 11, 2023

Mainland China’s regulatory evolution brings greater access to novel drugs
Ruchita Kumar, Ph.D.
Senior Manager, Healthcare Research & Data Analytics, China In-Depth
Clarivate
Life Sciences and Healthcare
May 8, 2023

Building a business through economic uncertainty: tales from the biotech trenches